These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 3287749)
81. [Criteria for selection of the first, second and third generation cephem antibiotics. 4. Urology]. Ishigami J Nihon Rinsho; 1984 Mar; 42(3):719-20. PubMed ID: 6471469 [No Abstract] [Full Text] [Related]
82. Penicillin and related antibiotics: gram-negative infections: urine. Brumfitt W J R Coll Physicians Lond; 1972 Jan; 6(2):194-202. PubMed ID: 5061042 [No Abstract] [Full Text] [Related]
83. [Clinical experimentation with aztreonam in infections of the urinary tract]. Martini G; Romano G; Pento C; Nubile G; Parogna A; Tresca E Minerva Urol Nefrol; 1986; 38(2):173-6. PubMed ID: 3750158 [No Abstract] [Full Text] [Related]
84. [Monodose aztreonam in the prevention of infection after extracorporeal shockwave lithotripsy. Theoretical premises]. Puppo P; Caviglia C; Germinale F; Giuliani L Minerva Urol Nefrol; 1989; 41(2):109-13. PubMed ID: 2772776 [TBL] [Abstract][Full Text] [Related]
85. [Criteria for selection of the first, second and third generation cephem antibiotics. 4. Urology]. Ohkoshi M Nihon Rinsho; 1984 Mar; 42(3):717-8. PubMed ID: 6471468 [No Abstract] [Full Text] [Related]
86. Xanthomonas maltophilia: an emerging nosocomial pathogen. Marshall WF; Keating MR; Anhalt JP; Steckelberg JM Mayo Clin Proc; 1989 Sep; 64(9):1097-104. PubMed ID: 2682049 [TBL] [Abstract][Full Text] [Related]
88. [Aztreonam in complicated infections of the urinary tract]. Tizzani A; Casetta G; Piana P Minerva Urol Nefrol; 1986; 38(3):263-5. PubMed ID: 3810387 [No Abstract] [Full Text] [Related]
89. [Therapeutic activity of aztreonam in the treatment of acute and chronic urinary infections]. Ranno S; Bellotti MG; Raimondi A; Minaldi G Minerva Urol Nefrol; 1986; 38(1):65-9. PubMed ID: 3738680 [No Abstract] [Full Text] [Related]
90. [Clinical experience with a new synthetic monobactam in urinary infections]. Pucciarini LG; Bussani F; Bosco A; Burattini MF Minerva Urol Nefrol; 1988; 40(4):267-73. PubMed ID: 3251366 [No Abstract] [Full Text] [Related]
91. Nosocomial enterococcal infections: association with use of third-generation cephalosporin antibiotics. Magnussen CR; Cave J Am J Infect Control; 1988 Dec; 16(6):241-5. PubMed ID: 3264666 [TBL] [Abstract][Full Text] [Related]
92. The role of colonization in the pathogenesis of nosocomial infections. Bonten MJ; Weinstein RA Infect Control Hosp Epidemiol; 1996 Mar; 17(3):193-200. PubMed ID: 8708364 [TBL] [Abstract][Full Text] [Related]
93. [New beta-lactam antibiotics: penems and monobactams]. Swierzy H Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1687-90. PubMed ID: 3268823 [No Abstract] [Full Text] [Related]
97. Aztreonam in the treatment of urinary tract infection. Childs SJ Am J Med; 1985 Feb; 78(2A):44-6. PubMed ID: 3881948 [TBL] [Abstract][Full Text] [Related]
98. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Brogden RN; Heel RC Drugs; 1986 Feb; 31(2):96-130. PubMed ID: 3512234 [TBL] [Abstract][Full Text] [Related]
99. Role of aztreonam in urinary tract infections. Roberts JA Urology; 1988 Jun; 31(6 Suppl):39-44. PubMed ID: 3287749 [TBL] [Abstract][Full Text] [Related]
100. [Current analysis of pathogen spectrum and resistance in bacterial urinary tract infections. Bacteriologic urine findings of hospitalized urologic patients]. Osterhage HR; Grups JW; Ackermann R; Frohmüller H Fortschr Med; 1984 Dec; 102(46):1178-80. PubMed ID: 6394458 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]